Calcium

vasoactive intestinal peptide ; Homo sapiens







28 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33502586 VIP modulates human macrophages phenotype via FPRL1 via activation of RhoA-GTPase and PLC pathways. 2021 Mar 2
2 31636447 Adaptive disinhibitory gating by VIP interneurons permits associative learning. 2019 Nov 2
3 24329967 Circadian pacemaking in cells and circuits of the suprachiasmatic nucleus. 2014 Jan 1
4 15451021 Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation. 2005 Jan 3
5 15921770 Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation. 2005 Jun 30 2
6 15020077 The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells. 2004 Apr 2
7 12097482 Coincident elevation of cAMP and calcium influx by PACAP-27 synergistically regulates vasoactive intestinal polypeptide gene transcription through a novel PKA-independent signaling pathway. 2002 Jul 1 5
8 10501227 Pituitary adenylate cyclase-activating polypeptide regulation of vasoactive intestinal polypeptide transcription requires Ca2+ influx and activation of the serine/threonine phosphatase calcineurin. 1999 Oct 1
9 9556032 NFAT interactions with the vasoactive intestinal peptide cytokine response element. 1998 Apr 1 1
10 9178630 Paracellular calcium transport across Caco-2 and HT29 cell monolayers. 1997 Jul 2
11 7538196 Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism. 1995 May 1
12 8523457 Inhibition by verapamil and diltiazem of agonist-stimulated contractile responses in mammalian ventricular cardiomyocytes. 1995 Sep 1
13 8074647 Human vasoactive intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways. 1994 Aug 30 1
14 7687662 Calcium regulation of vasoactive intestinal polypeptide mRNA abundance in SH-SY5Y human neuroblastoma cells. 1993 Aug 4
15 8227970 VIP modulates intracellular calcium oscillations in human lymphoblasts. 1993 Aug 2
16 1347631 Cyclic AMP accumulation alters calmodulin localization in SK-N-SH human neuroblastoma cells. 1992 Jan 1
17 2322933 Vasoactive intestinal polypeptide (VIP) induces calcium mobilization in the human neuroblastoma cell line SK-N-SH. 1990 Apr 30 2
18 2540281 Calcium uptake and protein phosphorylation in myenteric neurons, like the release of vasoactive intestinal polypeptide and acetylcholine, are frequency dependent. 1989 May 1
19 2456821 Adenylate cyclase activation is not sufficient to stimulate somatostatin release from dispersed cerebral cortical and diencephalic cells in glia-free cultures. 1988 May 31 3
20 3035984 Regulation of enkephalin, VIP, and chromogranin biosynthesis in actively secreting chromaffin cells. Multiple strategies for multiple peptides. 1987 3
21 3303295 The role of eicosanoids in the gastrointestinal tract. 1987 1
22 3018365 Vasoactive intestinal peptide augmentation of cholecystokinin-8-stimulated pepsinogen secretion: evidence for dual modulation of chief cell function. 1986 Jun 1
23 6091414 Calcium-dependent enhancement by carbachol of the VIP-induced cyclic AMP accumulation in cat submandibular gland. 1984 Apr 2
24 6189515 Binding of hormones and neuropeptides by calmodulin. 1983 Apr 12 1
25 666373 Hepatic inactivation of vasoactive intestinal peptide in man and dog. 1978 Jul 1
26 730072 Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. 1978 Nov 1
27 194562 Watery diarrhoea syndrome with episodic hypercalcaemia. 1977 Feb 1
28 835774 Release of VIP by calcium stimulation. 1977 Jan 4